18 Panel Test Cup with Xylazine & Kratom

18 Panel Urine Drug Test Cup with Xylazine and Kratom

The Serenity 18 Panel Test Cup combines specimen collection and preliminary screening for 18 drug, drug-class or metabolite targets in one 120 mL device.

This configuration includes dedicated xylazine and kratom panels together with fentanyl, EtG, ketamine, tramadol and commonly requested screening assays.

For forensic programs requiring an 18 panel drug test with xylazine, the XYL assay is a defining part of this configuration.

The cup also includes a separate KRA panel, allowing personnel to review xylazine and kratom screening results from the same urine specimen.

The integrated format brings collection and screening together while supporting an organized process for specimen identification, result recording and follow-up testing. Each assay produces its own qualitative result and must be interpreted individually according to the manufacturer’s instructions.

This cup includes one THC panel and does not include TCA.

Buyers can compare the available 18 panel drug test cups to select the configuration that matches their program’s required assays and intended use.

Drugs and Cutoff Levels

This 18 panel drug test cup includes the following screening panels and cutoff levels:

Each row represents a separate screening panel. This configuration includes 18 panels with one THC threshold.

Cutoff levels are screening thresholds. They do not measure dosage, establish impairment or determine the exact time of exposure. Follow the manufacturer’s instructions supplied with the device for interpretation and confirmation requirements.

Xylazine, Kratom and Specialty Screening in One Cup

This configuration combines six specialty panels with twelve additional screening targets. Buyers should check the complete list when selecting a cup or arranging a repeat order.

Xylazine: The XYL panel provides dedicated preliminary urine screening for xylazine. Its inclusion should be verified separately when comparing products because the presence of an opiate or fentanyl panel does not establish that a cup includes XYL.

Kratom: The KRA panel adds kratom screening to this configuration. Refer to the exact product insert for the assay’s target analyte and cross-reactivity information. Our guide explains why kratom screening depends on a dedicated KRA panel.

Fentanyl: The fentanyl assay is separate from the opiate, oxycodone, methadone and buprenorphine panels. Personnel should review and record the result for each applicable assay.

EtG: The ethyl glucuronide panel screens for an alcohol-related metabolite in urine. It does not provide a blood alcohol concentration or establish current impairment.

Ketamine and tramadol: Separate KET and TRA panels are included for programs requiring these targets. Their results should be recorded independently from the other screening panels.

The combination of XYL, KRA, FEN, EtG, KET and TRA identifies this particular cup. Other 18 panel products may contain a different selection of assays.

Key Features of the Serenity 18 Panel Xylazine Cup

• Xylazine and kratom screening: Dedicated XYL and KRA assays in the same device.
• Additional specialty panels: Includes fentanyl, EtG, ketamine and tramadol.
• 18 separate screening panels: A defined configuration for buyers matching a written testing requirement.
• Integrated collection and testing: Collect and screen the urine specimen in one cup.
• 120 mL cup format: A specified device size for purchasing and supply planning.
• Individual assay results: Review each panel separately during result documentation.
• Bulk purchasing options: Quantity pricing for eligible forensic programs and institutional buyers.

How to Use the 18 Panel Urine Drug Test

Follow the manufacturer’s instructions supplied with the exact device. The following steps provide a general overview of collection and preliminary screening.

1. Prepare the device: Confirm the product configuration, package condition and printed expiration date. Check that storage conditions meet the manufacturer’s requirements.
2. Identify the specimen: Follow your organization’s procedures for donor identification, labeling and collection documentation.
3. Collect the urine: Collect directly into the cup using the volume specified in the product insert. The 120 mL cup capacity is not the required collection volume.
4. Secure the lid: Close the cup as directed and complete the collection checks required by the manufacturer and your testing program.
5. Allow the panels to develop: Position the device as instructed and use a timer to follow the specified reading window.
6. Read and record each result: Check the Control and Test lines for all 18 assays, including XYL and KRA. Document invalid or non-negative findings and follow the required next steps.

For an illustrated explanation of the result patterns, review our guide to reading a drug test cup.

How to Read the Screening Results

Interpret every assay separately and within the manufacturer’s specified reading window.

Preliminary negative: A Control line and a Test line appear for the corresponding assay. Evaluate faint Test lines according to the product insert. Line darkness should not be used to estimate drug concentration.

Preliminary non-negative: A Control line appears without a Test line for the corresponding assay. Arrange appropriate laboratory confirmation before treating the screening finding as definitive.

Invalid: The required Control line does not appear. Do not report the affected assay as negative or non-negative. Follow the manufacturer’s troubleshooting instructions and repeat testing with a new device as directed.

A valid result on one panel does not establish that every other panel is valid. Review the required Control line for each assay before documenting its result.

Who Uses This Forensic Screening Configuration?

This configuration is intended for buyers selecting supplies for eligible forensic applications, including:

• Law enforcement testing programs.
• Court-related forensic screening.
• Probation and parole programs.
• Correctional and detention facilities.
• Laboratories supporting authorized forensic testing.

The product is offered as a Forensic Use Only configuration. Purchasing personnel should confirm that its labeled intended use and panel combination match the requirements of their organization.

Collection personnel also need the current manufacturer’s instructions and the procedures governing specimen handling, result documentation and laboratory confirmation.

For additional information, review our explanation of Forensic Use Only drug tests.

Detection Windows and Test Limitations

A screening cutoff does not establish a fixed detection window. Results can vary with the substance, timing and pattern of exposure, specimen concentration, assay cutoff and testing method.

A negative result does not exclude every possible exposure. The substance may be below the screening threshold, outside the assay’s detection capability or absent from the selected configuration.

Urine screening cannot determine impairment, dosage or the exact time of use. Unexpected findings and results affecting significant decisions require appropriate evaluation and confirmation. ARUP Consult’s drug testing guidance explains these limitations and the role of definitive testing.

This device is designed to screen urine specimens. It should not be used to test powders, pills or other substances directly.

Bulk 18 panel drug test with Kratom, Xylazine Drug Test Cups

DrugTestingCup.com offers quantity pricing for this xylazine and kratom configuration. Buyers can select the available order quantities on this page or request assistance with larger purchasing requirements.

For repeat orders, identify the product by SKU SM-CDOA-5185-FUO and confirm the required XYL, KRA, FEN, EtG, KET and TRA panels. This helps purchasing teams distinguish it from other 18 panel cups with different specialty assays.

Free shipping is available on qualifying orders of 100 or more cups, with same-day shipping on qualifying orders placed before 3 PM EST.

For purchasing guidance, review our bulk drug test cup buying guide. Organizations arranging larger orders can contact DrugTestingCup.com for assistance.

Frequently Asked Questions

What does this 18 panel urine drug test screen for?

This configuration includes AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP, THC, TRA, KET, FEN, EtG, KRA and XYL. It provides 18 screening panels, including dedicated xylazine and kratom assays.

Does this 18 panel cup include xylazine?

Yes. The configuration includes a dedicated XYL screening panel with a listed cutoff of 1,000 ng/mL. Interpret the xylazine result separately from the other assays.

Does this cup test for kratom?

Yes. A KRA screening panel with a listed cutoff of 500 ng/mL is included. Refer to the exact manufacturer’s insert for the assay’s target analyte and cross-reactivity information.

Does this cup include fentanyl, EtG and ketamine?

Yes. The listed configuration includes fentanyl at 20 ng/mL, EtG at 300 ng/mL and ketamine at 1,000 ng/mL. Each assay provides a separate preliminary screening result.

Does this configuration include TCA or two THC panels?

No. This configuration includes one THC panel at 50 ng/mL and does not include TCA. Buyers requiring TCA or two THC thresholds should select a different configuration.

Is this 18 panel urine test CLIA waived?

This product is offered as a Forensic Use Only configuration. Buyers requiring CLIA-waived testing should select a product with documentation supporting that status and intended use.

What should happen after a non-negative result?

Follow the testing program’s specimen-handling and result-review procedures, and obtain appropriate laboratory confirmation before treating the preliminary screening finding as definitive.

Can I order this xylazine and kratom cup in bulk?

Yes. Quantity pricing is available through the product’s purchasing options. Use SKU SM-CDOA-5185-FUO when requesting assistance with bulk or repeat orders.